EyePoint Pharmaceuticals Stock (NASDAQ: EYPT) stock price, news, charts, stock research, profile.
You can purchase shares of EyePoint Pharmaceuticals (NASDAQ:EYPT) through any online brokerage.
Other companies in EyePoint Pharmaceuticals’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
EyePoint Pharmaceuticals has a consensus price target of $30.50.
The stock price for EyePoint Pharmaceuticals (NASDAQ: EYPT) is $7.1 last updated December 20, 2024 at 4:01 PM EST.
There are no upcoming dividends for EyePoint Pharmaceuticals.
EyePoint Pharmaceuticals’s Q4 earnings are confirmed for Thursday, March 6, 2025.
There is no upcoming split for EyePoint Pharmaceuticals.
EyePoint Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.